TrialReady: A Real-Time Continuous Symptom Monitoring Platform to Improve GLP-1 Study Adherence, Reduce Trial Risk Metrics, and Track Multimodal Changes in Physiological Endpoints
Time: 11:10 am
day: Day Two
Details:
- Review multidomain patterns of GLP-1 associated symptoms
- Introduce TrialReady as the only platform to monitor GLP-1 associated symptoms in real time
- Discuss behavioral characterization tools to improve adherence and reduce dropout
